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Abstract
In this population-based study, all 314 episodes of b-haemolytic
streptococcal bacteraemia in adult patients in the Pirkanmaa
area, Finland, during the 10-year period 1995–2004 were ret-
rospectively reviewed. Altogether, 92 cases of bacteraemia
caused by Lanceﬁeld group A b-haemolytic streptococci (GAS),
76 caused by group B b-haemolytic streptococci (GBS), 18
caused by group C b-haemolytic streptococci (GCS) and 128
caused by group G b-haemolytic streptococci (GGS) were
identiﬁed. The most important ﬁnding was that the incidence
of GGS increased during the study period. Disruption of the
cutaneous barrier was a very common predisposing factor
in GAS and GGS bacteraemias. Skin infections were the pre-
senting clinical manifestations in two-thirds of GAS and GGS
bacteraemias.
Keywords: Bacteraemia, b-haemolytic, clinical presentations,
epidemiology, streptococci
Original Submission: 11 April 2008; Revised Submission:
21 July 2008; Accepted: 29 July 2008
Editor: P. Tassios
Clin Microbiol Infect 2009; 15: 286–288
10.1111/j.1469-0691.2008.02672.x
Corresponding author and reprint requests: S. Rantala,
Department of Internal Medicine, Tampere University Hospital,
PO Box 2000, FIN-33521 Tampere, Finland
E-mail: sari.rantala@pshp.ﬁ
Lanceﬁeld group A streptococci (GAS), group B streptococci
(GBS), group C streptococci (GCS) and group G strepto-
cocci (GGS) are part of the normal ﬂora of the pharynx,
skin, intestinal tract and vagina [1] but also cause a variety of
invasive and non-invasive infections. This study focuses on
the estimation of the incidence of bacteraemia caused
by GAS, GBS, GCS and GGS and the determination of the
predisposing factors, underlying diseases, presenting clinical
manifestations and outcome of these diseases during a
10-year period.
The medical records of all adult (over 16 years of age)
patients in the Pirkanmaa Health District (HD), Finland with
one or more blood cultures positive for GAS, GBS, GCS or
GGS from January 1995 to December 2004 were retrospec-
tively reviewed. Pirkanmaa HD (460 000 inhabitants) har-
bours one tertiary-care hospital (Tampere University
Hospital) and four other hospitals, including Hatanpa¨a¨ City
Hospital and the district hospitals in Valkeakoski, Vammala
and Ma¨ntta¨. Laboratory records were screened to identify all
blood cultures positive for b-haemolytic streptococci during
the study period. The case deﬁnition included all patients
with a positive blood culture for GAS, GBS, GCS or GGS
combined with a clinical picture compatible with septicaemia.
An infectious disease specialist (SR) reviewed all of the
patient records. Cellulitis included infections of skin and
underlying tissue (erysipelas and deeper non-necrotizing soft
tissue infections).
The routine blood cultures were drawn into aerobic and
anaerobic bottles. During the study period, the BACTEC
NR 730 (only in 1995) and BACTEC 9240 (BD Diagnostic
Systems, Sparks, MD, USA) (1996–2004) blood culture sys-
tems were used. In the district hospitals, the signal blood
culture system (Oxoid, Cambridge, UK) was used until 2003.
The Lanceﬁed serogroups were determined by latex aggluti-
nation using the Streptex latex test system (Remel Europe
Ltd, Dartford, UK). All isolates were also identiﬁed biochem-
ically using the Rapid ID 32 STREP system (bioMe´rieux SA,
Marcy-1’Etoile, France).
The categorical data were analysed using the chi-square
test or Fisher’s exact test as appropriate. The non-paramet-
ric data were analysed by Mann–Whitney U-test. Change in
incidence was analysed by Poisson regression. A two-sided
p-value <0.05 was regarded as statistically signiﬁcant.
b-Haemolytic streptococci grew in 314 cultures, distrib-
uted as follows: GAS, 92 cases (29%); GBS, 76 cases (24%);
GCS, 18 cases (6%); and GGS, 128 cases (41%). All GAS
were identiﬁed as Streptococcus pyogenes, all GBS as Strepto-
coccus agalactiae, and all GGS as Streptococcus dysgalactiae
subsp. equisimilis. Six of the GCS were conﬁrmed to be
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Streptococcus equi subsp. zooepidemicus and 12 to be S. dysga-
lactiae subsp. equisimilis. Positive blood cultures were
obtained from 309 patients. Six patients had recurrent b-
haemolytic bacteraemia within the study period (two GBS
and four GGS).
The presenting clinical manifestations associated with bac-
teraemia are given in Table 1. In all cases, the causative
microbe was susceptible to the empirical antibiotic therapy
given. The 30-day mortality was 13%, being highest in
patients with GCS (22%); mortality was 15% in patients with
GAS, 7% in those with GBS, and 15% in those with GGS.
The incidence of GGS bacteraemia increased from 1.8
cases per 100 000 population in 1995 to 4.3 cases per
100 000 population in 2004 (Fig. 1); this was a statistically
signiﬁcant increase (p 0.013). The incidence of GAS or GBS
bacteraemia ﬂuctuated over time (Fig. 1). The number of
blood cultures taken increased during the study period.
However, the incidence of positive blood cultures (all cases
of bacteria included) increased from 279/100 000 in 1995 to
368/100 000 in 2004 (1.3-fold), and the incidence of GGS
increased from 1.81/100 000 to 4.32/100 000 during the
same period (2.4-fold).
There were no changes in laboratory methodology during
the study period, which could explain the increase in the
incidence of GGS. An outbreak caused by S. equi subsp. zoo-
epidemicus associated with consumption of unpasteurized
goat cheese occurred in 2003 (six cases), and has been
reported elsewhere [2].
Alcoholism (an alcohol-related medical or social problem)
was common in patients with GAS bacteraemia (26%), and
diabetes was common in patients with GBS (32%) and GGS
(23%) bacteraemia. Malignancies were common in patients
with GBS being higher than in previous studies [3,4] (38%)
bacteraemia.
Disruption of the cutaneous barrier was more common in
patients with GAS (58%) or GGS (53%) bacteraemia than in
those with GBS (32%) bacteraemia (p 0.001 and p 0.003,
respectively). Twenty-six per cent of all patients had chronic
eczema or skin erosion, 4% psoriasis, 13% chronic ulcer,
10% traumatic wounds and 3% operation wounds as a proba-
ble or possible portal of entry. A trauma during the previous
month was a common predisposing factor in cases of GAS
bacteraemia (27%). A history of previous cellulitis that was
treated in a hospital or in an outpatient clinic at least
1 month prior to the current episode of bacteraemia was
TABLE 1. Comparison of the presenting clinical manifestations of b-haemolytic streptococcal bacteraemias by Lanceﬁeld
group
Presenting clinical manifestationa
GAS
n = 92
n (%)
GBS
n = 76
n (%)
GCS
n = 18
n (%)
GGS
n = 128
n (%)
All
n = 314
n (%) Overall p-value
Skin/soft tissue infection 65 (71) 34 (45) 10 (56) 88 (69) 197 (63) 0.002
Cellulitis 36 (39) 26 (34) 8 (44) 73 (57) 143 (46) 0.006
Fasciitis 7 (8) 0 0 1 (1) 8 (3) 0.008
Infected wound or eczema 24 (26) 12 (16) 1 (6) 23 (18) 60 (19) 0.15
Deep abscessb 10 (11) 5 (7) 0 2 (2) 17 (5) 0.02
Pneumonia 16 (17) 3 (4) 2 (11) 12 (9) 33 (11) 0.04
Urinary tract infection 1 (1) 7 (9) 0 1 (1) 9 (3) 0.008
Puerperal sepsis 7 (8) 6 (8) 0 4 (3) 17 (5) 0.27
Arthritis (all) 5 (6) 3 (4) 1 (6) 11 (9) 20 (6) 0.58
Prosthetic joint infection 0 3 (4) 0 6 (5) 9 (3) 0.14
Osteomyelitis 4 (4) 5 (7) 0 6 (5) 15 (5) 0.83
Meningitis 3 (3) 0 0 1 (1) 4 (1) 0.34
Endocarditis 1 (1) 3 (4) 1 (6) 2 (2) 7 (2) 0.30
Bacteraemia without deﬁned focus 10 (11) 21 (28) 8 (44) 21 (16) 61 (19) 0.002
GAS, Lanceﬁeld group A b-haemolytic streptococci; GBS, Lanceﬁeld group B b-haemolytic streptococci; GCS, Lanceﬁeld group C b-haemolytic streptococci; GGS, Lanceﬁeld
group G b-haemolytic streptococci.
aOne patient may have one or more clinical manifestations.
bIncluded empyema in ﬁve patients, intra-abdominal abscess in three, epidural abscess in two, psoas abscess in one, femoral abscess in one, abscess of operation region
in one.
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FIG. 1. Incidence/100 000 inhabitants/year of bacteraemia caused by
Lanceﬁeld group A streptococci (GAS), Lanceﬁeld group B strepto-
cocci (GBS), Lanceﬁeld group C streptococci (GCS) and Lanceﬁeld
group G streptococci (GGS) in Pirkanmaa Health District 1995–2004.
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found more often in patients with GBS (20%) or GGS (29%)
bacteraemia than in those with GAS (4%) bacteraemia
(p 0.002 and p <0.001, respectively).
The most important ﬁnding here was the increasing inci-
dence of GGS bacteraemia during the study period. A similar
trend in the incidence of GGS bacteraemia has also been
noted in some other geographical areas [5]. However, the
population-based data concerning the incidence of GGS
bacteraemia are limited [5–7]. The reason for the continuous
increase in GGS bacteraemia remains unclear, although pro-
longed survival of adults with underlying diseases (e.g. diabetes
mellitus, cancer and heart disease) may be one contributing
factor [8]. However, this cannot be the only explanation,
as no signiﬁcant difference in age, presence of diabetes or
cardiovascular diseases was found among patients with GGS
bacteraemia as compared with those with GBS or GCS
bacteraemia (data not shown). In addition to a change in the
host factors, GGS virulence factors may have a role [9]. The
average annual incidence and the ﬂuctuating pattern of
invasive GAS infections were in concordance with those in
previous reports [5,10–13].
The important new ﬁnding was that a disruption of the
cutaneous barrier was a very common predisposing factor in
GAS and GGS bacteraemia, occurring more frequently than
previous reports would imply [5,11,14–16]. As described
elsewhere, skin infections were the most common clinical
manifestation in all groups [3,5,8,10,15–20]. Skin infections
were the presenting clinical manifestations in two-thirds of
GAS and GGS bacteraemias. It is known that GAS and GGS
share virulence factors. This may be one explanation for the
similar spectrum of disease that they cause. A new ﬁnding
was that a history of previous cellulitis was very common in
GBS and GGS bacteraemia.
It is concluded that the incidence of GGS bacteraemia is
increasing in Pirkanmaa HD, Finland. Disruption of the cuta-
neous barrier as a predisposing factor and skin infections as
a presenting focus of infection were found very commonly in
patients with GAS and GGS bacteraemia.
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